Hazard

This practical guidance is designed to assist programme specialists to implement COVID19 RCCE activities for and with refugees, IDPs, migrants and host communities vulnerable to the pandemic. The guidance highlights key challenges and barriers faced by these people in accessing COVID19 health-related information and presents key considerations and recommendations for planning and implementing RCCE activities. […]

Testing is a critical component of epidemic response, as it allows public health authorities to identify both individual cases and emerging hotspots of COVID-19, and to rapidly implement effective epidemic control measures such as isolation and treatment and contact tracing around confirmed cases to slow and stop the spread of the virus. National Societies, as

Esta guía proporciona explicaciones de los tipos y fiabilidad de los diferentes tipos de pruebas y estrategias. Su objetivo es informar la toma de decisiones efectiva por parte de las Sociedades Nacionales involucradas en las pruebas de COVID-19, o que están considerando apoyar en tales actividades.

Les présentes orientations exposent les différents types de tests et la fiabilité de chacun d’entre eux ainsi que des différentes stratégies de dépistage. Elles sont conçues pour permettre aux Sociétés nationales participant ou envisageant de contribuer au dépistage du COVID-19 de prendre des décisions éclairées.

Guidance from the Inter-Agency task team to address HIV in humanitarian emergencies, in recognition that responding to COVID-19 will put significant pressure on already weak health systems, potentially resulting in serious disruptions in HIV care and treatment. Without ARVs, PLHIV are immunocompromised and may be at higher risk of becoming infected with COVID-19, and potentially

This guidance provides explanations of the types and reliability of different test types and strategies. It is meant to inform effective decision-making by National Societies involved in or considering support to COVID-19 testing. Last updated on October 2020.

Different transmission pathways of the virus and emerging evidence